Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Exact formula for the horizontal-to-vertical displacement ratio of Rayleigh waves in layered orthotropic half-spaces.

Vinh PC, Tuan TT, Hue LT, Anh VTN, Dung TTT, Linh NTK, Malischewsky P.

J Acoust Soc Am. 2019 Aug;146(2):1279. doi: 10.1121/1.5122184.

PMID:
31472571
2.

Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake.

Renguet E, Ginion A, Gélinas R, Bultot L, Auquier J, Robillard Frayne I, Daneault C, Vanoverschelde JL, Des Rosiers C, Hue L, Horman S, Beauloye C, Bertrand L.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H432-H445. doi: 10.1152/ajpheart.00738.2016. Epub 2017 Jun 23.

3.

Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.

Johanns M, Pyr Dit Ruys S, Houddane A, Vertommen D, Herinckx G, Hue L, Proud CG, Rider MH.

Cell Signal. 2017 Aug;36:212-221. doi: 10.1016/j.cellsig.2017.05.010. Epub 2017 May 11.

PMID:
28502587
4.

Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.

Houddane A, Bultot L, Novellasdemunt L, Johanns M, Gueuning MA, Vertommen D, Coulie PG, Bartrons R, Hue L, Rider MH.

Cell Signal. 2017 Jun;34:23-37. doi: 10.1016/j.cellsig.2017.02.019. Epub 2017 Feb 22.

PMID:
28235572
5.

Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.

Van Steenbergen A, Balteau M, Ginion A, Ferté L, Battault S, Ravenstein CM, Balligand JL, Daskalopoulos EP, Gilon P, Despa F, Despa S, Vanoverschelde JL, Horman S, Koepsell H, Berry G, Hue L, Bertrand L, Beauloye C.

Sci Rep. 2017 Jan 27;7:41166. doi: 10.1038/srep41166.

6.

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.

Johanns M, Lai YC, Hsu MF, Jacobs R, Vertommen D, Van Sande J, Dumont JE, Woods A, Carling D, Hue L, Viollet B, Foretz M, Rider MH.

Nat Commun. 2016 Mar 8;7:10856. doi: 10.1038/ncomms10856.

7.

Real-time mobile teledermoscopy for skin cancer screening targeting an agricultural population: an experiment on 289 patients in France.

Hue L, Makhloufi S, Sall N'Diaye P, Blanchet-Bardon C, Sulimovic L, Pomykala F, Colomb M, Baccard M, Lassau F, Reuter G, Keller F, Fite C, Triller R, Crémieux AC.

J Eur Acad Dermatol Venereol. 2016 Jan;30(1):20-4. doi: 10.1111/jdv.13404. Epub 2015 Nov 16.

PMID:
26568080
8.
9.

Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.

Plaideau C, Lai YC, Kviklyte S, Zanou N, Löfgren L, Andersén H, Vertommen D, Gailly P, Hue L, Bohlooly-Y M, Hallén S, Rider MH.

Chem Biol. 2014 Nov 20;21(11):1497-1510. doi: 10.1016/j.chembiol.2014.09.013.

10.

Controlled growth of 1D and 2D ZnO nanostructures on 4H-SiC using Au catalyst.

Dahiya AS, Opoku C, Alquier D, Poulin-Vittrant G, Cayrel F, Graton O, Hue LP, Camara N.

Nanoscale Res Lett. 2014 Aug 3;9(1):379. doi: 10.1186/1556-276X-9-379. eCollection 2014.

11.

AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes.

Balteau M, Van Steenbergen A, Timmermans AD, Dessy C, Behets-Wydemans G, Tajeddine N, Castanares-Zapatero D, Gilon P, Vanoverschelde JL, Horman S, Hue L, Bertrand L, Beauloye C.

Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1120-33. doi: 10.1152/ajpheart.00210.2014. Epub 2014 Aug 15.

12.

Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Taegtmeyer H, Beauloye C, Harmancey R, Hue L.

Am J Physiol Heart Circ Physiol. 2013 Dec;305(12):H1693-7. doi: 10.1152/ajpheart.00854.2012. Epub 2013 Oct 4. Review.

13.

Differential regulation of eEF2 and p70S6K by AMPKalpha2 in heart.

Demeulder B, Zarrinpashneh E, Ginion A, Viollet B, Hue L, Rider MH, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L.

Biochim Biophys Acta. 2013 Jun;1832(6):780-90. doi: 10.1016/j.bbadis.2013.02.015. Epub 2013 Mar 4.

14.

Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells.

Plaideau C, Liu J, Hartleib-Geschwindner J, Bastin-Coyette L, Bontemps F, Oscarsson J, Hue L, Rider MH.

FASEB J. 2012 Jun;26(6):2685-94. doi: 10.1096/fj.11-198168. Epub 2012 Mar 13.

PMID:
22415305
15.

AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase.

Bultot L, Guigas B, Von Wilamowitz-Moellendorff A, Maisin L, Vertommen D, Hussain N, Beullens M, Guinovart JJ, Foretz M, Viollet B, Sakamoto K, Hue L, Rider MH.

Biochem J. 2012 Apr 1;443(1):193-203. doi: 10.1042/BJ20112026.

PMID:
22233421
16.

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.

Stephenne X, Foretz M, Taleux N, van der Zon GC, Sokal E, Hue L, Viollet B, Guigas B.

Diabetologia. 2011 Dec;54(12):3101-10. doi: 10.1007/s00125-011-2311-5. Epub 2011 Sep 23.

17.

NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.

Balteau M, Tajeddine N, de Meester C, Ginion A, Des Rosiers C, Brady NR, Sommereyns C, Horman S, Vanoverschelde JL, Gailly P, Hue L, Bertrand L, Beauloye C.

Cardiovasc Res. 2011 Nov 1;92(2):237-46. doi: 10.1093/cvr/cvr230. Epub 2011 Aug 22.

PMID:
21859816
18.

Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.

Ginion A, Auquier J, Benton CR, Mouton C, Vanoverschelde JL, Hue L, Horman S, Beauloye C, Bertrand L.

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H469-77. doi: 10.1152/ajpheart.00986.2010. Epub 2011 May 20.

19.

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure.

Beauloye C, Bertrand L, Horman S, Hue L.

Cardiovasc Res. 2011 May 1;90(2):224-33. doi: 10.1093/cvr/cvr034. Epub 2011 Feb 1. Review.

PMID:
21285292
20.

Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum- and glucocorticoid-induced protein kinase 3).

Mouton V, Toussaint L, Vertommen D, Gueuning MA, Maisin L, Havaux X, Sanchez-Canedo C, Bertrand L, Dequiedt F, Hemmings BA, Hue L, Rider MH.

Biochem J. 2010 Oct 15;431(2):267-75. doi: 10.1042/BJ20101089.

21.

AMP-activated protein kinase induces actin cytoskeleton reorganization in epithelial cells.

Miranda L, Carpentier S, Platek A, Hussain N, Gueuning MA, Vertommen D, Ozkan Y, Sid B, Hue L, Courtoy PJ, Rider MH, Horman S.

Biochem Biophys Res Commun. 2010 Jun 4;396(3):656-61. doi: 10.1016/j.bbrc.2010.04.151. Epub 2010 May 8.

PMID:
20438708
22.

Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.

Sanchez Canedo C, Demeulder B, Ginion A, Bayascas JR, Balligand JL, Alessi DR, Vanoverschelde JL, Beauloye C, Hue L, Bertrand L.

Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E761-9. doi: 10.1152/ajpendo.00421.2009. Epub 2010 Jan 5.

23.

The Randle cycle revisited: a new head for an old hat.

Hue L, Taegtmeyer H.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E578-91. doi: 10.1152/ajpendo.00093.2009. Epub 2009 Jun 16. Review.

24.

Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.

Da Silva Morais A, Lebrun V, Abarca-Quinones J, Brichard S, Hue L, Guigas B, Viollet B, Leclercq IA.

J Hepatol. 2009 Mar;50(3):489-500. doi: 10.1016/j.jhep.2008.10.027. Epub 2008 Dec 26.

PMID:
19155087
25.

Myosin light chains are not a physiological substrate of AMPK in the control of cell structure changes.

Bultot L, Horman S, Neumann D, Walsh MP, Hue L, Rider MH.

FEBS Lett. 2009 Jan 5;583(1):25-8. doi: 10.1016/j.febslet.2008.11.022. Epub 2008 Dec 4.

26.

AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol.

Zarrinpashneh E, Beauloye C, Ginion A, Pouleur AC, Havaux X, Hue L, Viollet B, Vanoverschelde JL, Bertrand L.

Biochem Biophys Res Commun. 2008 Nov 28;376(4):677-81. doi: 10.1016/j.bbrc.2008.09.057. Epub 2008 Sep 21.

PMID:
18812163
27.

Beyond AICA riboside: in search of new specific AMP-activated protein kinase activators.

Guigas B, Sakamoto K, Taleux N, Reyna SM, Musi N, Viollet B, Hue L.

IUBMB Life. 2009 Jan;61(1):18-26. doi: 10.1002/iub.135. Review.

28.

Comparative Fe and Zn K-edge X-ray absorption spectroscopic study of the ferroxidase centres of human H-chain ferritin and bacterioferritin from Desulfovibrio desulfuricans.

Toussaint L, Cuypers MG, Bertrand L, Hue L, Romão CV, Saraiva LM, Teixeira M, Meyer-Klaucke W, Feiters MC, Crichton RR.

J Biol Inorg Chem. 2009 Jan;14(1):35-49. doi: 10.1007/s00775-008-0422-3. Epub 2008 Sep 3.

PMID:
18766385
29.

Effects of marginal iron overload on iron homeostasis and immune function in alveolar macrophages isolated from pregnant and normal rats.

Ward RJ, Wilmet S, Legssyer R, Leroy D, Toussaint L, Crichton RR, Pierreux C, Hue L, Piette J, Srai SK, Solanky N, Klein D, Summer K.

Biometals. 2009 Apr;22(2):211-23. doi: 10.1007/s10534-008-9155-6. Epub 2008 Aug 9.

30.

AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase.

Horman S, Morel N, Vertommen D, Hussain N, Neumann D, Beauloye C, El Najjar N, Forcet C, Viollet B, Walsh MP, Hue L, Rider MH.

J Biol Chem. 2008 Jul 4;283(27):18505-12. doi: 10.1074/jbc.M802053200. Epub 2008 Apr 21.

31.

Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK.

Luiken JJ, Vertommen D, Coort SL, Habets DD, El Hasnaoui M, Pelsers MM, Viollet B, Bonen A, Hue L, Rider MH, Glatz JF.

Cell Signal. 2008 Mar;20(3):543-56. doi: 10.1016/j.cellsig.2007.11.007. Epub 2007 Nov 26.

PMID:
18164589
32.

Lack of starvation-induced activation of AMP-activated protein kinase in the hypothalamus of the Lou/C rats resistant to obesity.

Taleux N, De Potter I, Deransart C, Lacraz G, Favier R, Leverve XM, Hue L, Guigas B.

Int J Obes (Lond). 2008 Apr;32(4):639-47. Epub 2007 Dec 4.

PMID:
18059408
33.

Antagonistic effects of leucine and glutamine on the mTOR pathway in myogenic C2C12 cells.

Deldicque L, Sanchez Canedo C, Horman S, De Potter I, Bertrand L, Hue L, Francaux M.

Amino Acids. 2008 Jun;35(1):147-55. Epub 2007 Nov 5.

PMID:
17978888
34.

Effects of contraction and insulin on protein synthesis, AMP-activated protein kinase and phosphorylation state of translation factors in rat skeletal muscle.

Miranda L, Horman S, De Potter I, Hue L, Jensen J, Rider MH.

Pflugers Arch. 2008 Mar;455(6):1129-40. Epub 2007 Oct 24.

PMID:
17957382
35.

The AMP-activated protein kinase: more than an energy sensor.

Hue L, Rider MH.

Essays Biochem. 2007;43:121-37. Review.

PMID:
17705797
36.

Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1.

Stéphenne X, Najimi M, Ngoc DK, Smets F, Hue L, Guigas B, Sokal EM.

Cell Transplant. 2007;16(4):409-19.

PMID:
17658131
37.

Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways.

Deldicque L, Theisen D, Bertrand L, Hespel P, Hue L, Francaux M.

Am J Physiol Cell Physiol. 2007 Oct;293(4):C1263-71. Epub 2007 Jul 25.

38.

Enhancement of classification accuracy of a time-frequency approach for an EEG-based brain-computer interface.

Yamawaki N, Wilke C, Hue L, Liu Z, He B.

Methods Inf Med. 2007;46(2):155-9.

PMID:
17347747
39.

AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside.

Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, Viollet B, Hue L.

Biochem J. 2007 Jun 15;404(3):499-507.

40.

High-resolution X-ray structures of human apoferritin H-chain mutants correlated with their activity and metal-binding sites.

Toussaint L, Bertrand L, Hue L, Crichton RR, Declercq JP.

J Mol Biol. 2007 Jan 12;365(2):440-52. Epub 2006 Oct 7.

PMID:
17070541
41.

Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia.

Zarrinpashneh E, Carjaval K, Beauloye C, Ginion A, Mateo P, Pouleur AC, Horman S, Vaulont S, Hoerter J, Viollet B, Hue L, Vanoverschelde JL, Bertrand L.

Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2875-83. Epub 2006 Jul 28.

42.

Evaluation of the role of protein kinase Czeta in insulin-induced heart 6-phosphofructo-2-kinase activation.

Mouton V, Vertommen D, Bertrand L, Hue L, Rider MH.

Cell Signal. 2007 Jan;19(1):52-61. Epub 2006 Jun 3.

PMID:
16829026
43.

Optical and EPR spectroscopic studies of demetallation of hemin by L-chain apoferritins.

Carette N, Hagen W, Bertrand L, de Val N, Vertommen D, Roland F, Hue L, Crichton RR.

J Inorg Biochem. 2006 Aug;100(8):1426-35. Epub 2006 Jun 16.

PMID:
16781777
44.

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.

Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F.

J Physiol. 2006 Jul 1;574(Pt 1):41-53. Epub 2006 Apr 27. Review.

45.

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.

Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, Andreelli F, Viollet B, Hue L.

Diabetes. 2006 Apr;55(4):865-74.

46.

AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B.

Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B, Hue L, Vanoverschelde JL.

Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H239-50. Epub 2006 Feb 17.

47.

Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L, Rider MH.

J Biol Chem. 2006 Mar 3;281(9):5335-40. Epub 2005 Dec 9.

48.

The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.

Gresh L, Bourachot B, Reimann A, Guigas B, Fiette L, Garbay S, Muchardt C, Hue L, Pontoglio M, Yaniv M, Klochendler-Yeivin A.

EMBO J. 2005 Sep 21;24(18):3313-24. Epub 2005 Sep 1.

49.

Coordinated behavior of mitochondria in both space and time: a reactive oxygen species-activated wave of mitochondrial depolarization.

Brady NR, Elmore SP, van Beek JJ, Krab K, Courtoy PJ, Hue L, Westerhoff HV.

Biophys J. 2004 Sep;87(3):2022-34.

50.

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L.

Biochem J. 2004 Aug 1;381(Pt 3):561-79. Review.

Supplemental Content

Support Center